(1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-1H,2H,3H,4H,4aH,5H,6H,9H,11bH-[1,3]dioxolo[4,5-j]phenanthridin-6-one
Structure Info
- Chemspace ID
- CSSB00102512220 (In-Stock Building Blocks)
- MFCD
- MFCD31562117
- IUPAC Name
- (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-1H,2H,3H,4H,4aH,5H,6H,9H,11bH-[1,3]dioxolo[4,5-j]phenanthridin-6-one
- Mol formula
- C14H15NO8
- Mol weight
- 325 Da
- Catalog Number(s)
- 96281-31-1, A616875, AA01FNPB, ACM96281311, AG01FNS3, AGN-PC-0W5SW8, AR01FOH3, AY10075, CSC102512220, EC01FPXV, HY-102010, OR1130102, P173600, ST01FP8V, T73640, TX01FOXR, Y3310234, ZXC321498
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -1.92
- Heavy atoms count
- 23
- Rotatable bond count
- 0
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 149
- Hydrogen bond acceptors count
- 8
- Hydrogen bond donors count
- 6
- Zoom the structure
- CSSB00102512220
Items Overall 5 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Angene International Limited | 10 days | China To: | 98 | 2 mg | 972.00 | |
Description: Pancratistatin; CAS: 96203-70-2 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 2 mg | 1,086.75 | |
| AA Blocks CN | 12 days | China To: | 98 | 2 mg | 1,563.10 | |
Description: Pancratistatin; CAS: 96203-70-2 | ||||||
| eNovation CN | 20 days | China To: | 98 | 2 mg | 1,357.00 | |
Description: Pancratistatin; CAS: 96203-70-2 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 98 | 2 mg | 1,521.30 | |
Description: Pancratistatin; CAS: 96203-70-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of (2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one - CSSB00102419905](/st/structure/200/b1977f4eca163d0e0ed864870d368785/O%255BC%2540H%255D1C%253DC2%255BC%2540%2540H%255D%2528NC%2528%253DO%2529C3%253DC%2528O%2529C4%253DC%2528OCO4%2529C%253DC23%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of 2,3,4,7-tetrahydroxy-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one - CSSB00159267986](/st/structure/200/221203ea1775fbb5db469e75ce936fb0/OC1C%253DC2C%2528NC%2528%253DO%2529C3%253DC%2528O%2529C4%253DC%2528OCO4%2529C%253DC23%2529C%2528O%2529C1O.png)
![Chemical structure of 8,11-dihydroxy-2H,10H-[1,3]dioxolo[4,5-b]xanthen-10-one - CSSB00159274484](/st/structure/200/5014654f9c8d27e7a5d66425d7ff337c/OC1%253DCC%253DC2OC3%253DCC4%253DC%2528OCO4%2529C%2528O%2529%253DC3C%2528%253DO%2529C2%253DC1.png)
![Chemical structure of (2R,3S,4R,4aS)-2,3,7-trihydroxy-4-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H,3H,4H,4aH,5H,6H,9H-[1,3]dioxolo[4,5-j]phenanthridin-6-one - CSSB14929136841](/st/structure/200/a95b3176eb440e32a1de7ed7ec83cc9e/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528O%255BC%2540H%255D2%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529C%253DC3%255BC%2540%2540H%255D2NC%2528%253DO%2529c2c%2528O%2529c4OCOc4cc32%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)

![Chemical structure of (2S,3R,4S,4aR,11bR)-2,3,4-trihydroxy-1H,2H,3H,4H,4aH,5H,6H,9H,11bH-[1,3]dioxolo[4,5-j]phenanthridin-6-one - CSSB14929136842](/st/structure/200/259b4c8c6cd1802e18b2f27846305414/O%255BC%2540H%255D1C%255BC%2540H%255D2%255BC%2540%2540H%255D%2528NC%2528%253DO%2529c3cc4OCOc4cc23%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of (10R,11R,15R)-2-hydroxy-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one - CSSB00102517880](/st/structure/200/de1d6d564eebf3e159379047f6910cff/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1O%2529%255BC%2540H%255D1%255BC%2540%2540H%255D2%255BC%2540H%255D%2528COC2%253DO%2529CC2%253DC%2528O%2529C3%253DC%2528OCO3%2529C%253DC12.png)
